Early prediction of acute kidney injury in patients with acute myocardial injury

Journal of Critical Care

Volumn 27, Issue 5, 2012, Pages 525.e1-525.e7

  Hsiao, Ping Gune ^a,b   Hsieh, Chien An ^a,c   Yeh, Chun Fu ^a   Wu, Hsueh Hua ^a   Shiu, Tzu Fang ^a   Chen, Yung Chang ^a   Chu, Pao Hsien ^a  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b CHIA YI CHRISTIAN HOSPITAL   (Taiwan)

^c BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

Author keywords

Acute kidney injury; Acute myocardial infarction; Biomarkers

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; CREATININE; CYSTATIN C; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERLEUKIN 18; INTERLEUKIN 6; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN;

ACUTE HEART INFARCTION; ACUTE KIDNEY FAILURE; ADULT; ARTICLE; BLOOD CLOT LYSIS; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY STENT; CREATININE BLOOD LEVEL; CYSTATIN C BLOOD LEVEL; DISEASE MARKER; ECHOCARDIOGRAPH; FEMALE; HEART CATHETERIZATION; HEART FUNCTION; HUMAN; HUMAN CELL; INCIDENCE; INSTITUTIONAL REVIEW; INTERLEUKIN 18 BLOOD LEVEL; INTERLEUKIN 6 BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN BLOOD LEVEL; PREDICTION; PROGNOSIS; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; TAIWAN; UROGENITAL SYSTEM PARAMETERS;

EID: 84867336146     PISSN: 08839441     EISSN: 15578615     Source Type: Journal    
DOI: 10.1016/j.jcrc.2012.05.003     Document Type: Article

References (44)

1. Thiele H., Hildebrand L., Schirdewahn C., et al. Impact of high-dose N-acetylcysteine versus placebo on contrast-induced nephropathy and myocardial reperfusion injury in unselected patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. The LIPSIA-N-ACC (Prospective, Single-Blind, Placebo-Controlled, Randomized Leipzig Immediate PercutaneouS Coronary Intervention Acute Myocardial Infarction N-ACC) Trial. J Am Coll Cardiol 2010, 55:2201-2209.
2. Marenzi G., Assanelli E., Campodonico J., et al. Acute kidney injury in ST-segment elevation acute myocardial infarction complicated by cardiogenic shock at admission. Crit Care Med 2010, 38:438-444.
3. Lau D.H., Huynh L.T., Chew D.P., Astley C.M., Soman A., Sanders P. Prognostic impact of types of atrial fibrillation in acute coronary syndromes. Am J Cardiol 2009, 104:1317-1323.
4. Goldberg A., Kogan E., Hammerman H., Markiewicz W., Aronson D. The impact of transient and persistent acute kidney injury on long-term outcomes after acute myocardial infarction. Kidney Int 2009, 76:900-906.
5. Bouzas-Mosquera A., Vazquez-Rodriguez J.M., Peteiro J., Alvarez-Garcia N. Acute kidney injury and long-term prognosis after acute myocardial infarction. Arch Intern Med 2009, 169:87.
6. Parikh C.R., Coca S.G., Wang Y., Masoudi F.A., Krumholz H.M. Long-term prognosis of acute kidney injury after acute myocardial infarction. Arch Intern Med 2008, 168:987-995.
7. Marenzi G., Moltrasio M., Assanelli E., et al. Impact of cardiac and renal dysfunction on inhospital morbidity and mortality of patients with acute myocardial infarction undergoing primary angioplasty. Am Heart J 2007, 153:755-762.
8. Bolognese L., Falsini G., Grotti S., et al. The contrast media and nephrotoxicity following coronary revascularization by primary angioplasty for acute myocardial infarction study: design and rationale of the CONTRAST-AMI study. J Cardiovasc Med (Hagerstown) 2010, 11:199-206.
9. Mishra J., Dent C., Tarabishi R., et al. Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet 2005, 365:1231-1238.
10. Parikh C.R., Mishra J., Thiessen-Philbrook H., et al. Urinary IL-18 is an early predictive biomarker of acute kidney injury after cardiac surgery. Kidney Int 2006, 70:199-203.
11. Astrom-Olsson K., Hedstrom E., Hulten L.M., et al. Dissociation of the inflammatory reaction following PCI for acute myocardial infarction. J Invasive Cardiol 2007, 19:452-456.
12. Zhu J., Yin R., Wu H., et al. Cystatin C as a reliable marker of renal function following heart valve replacement surgery with cardiopulmonary bypass. Clin Chim Acta 2006, 374:116-121.
13. Haase M., Bellomo R., Story D., Davenport P., Haase-Fielitz A. Urinary interleukin-18 does not predict acute kidney injury after adult cardiac surgery: a prospective observational cohort study. Crit Care 2008, 12:R96.
14. Liu K.D., Altmann C., Smits G., et al. Serum interleukin-6 and interleukin-8 are early biomarkers of acute kidney injury and predict prolonged mechanical ventilation in children undergoing cardiac surgery: a case-control study. Crit Care 2009, 13:R104.
15. Dennen P., Altmann C., Kaufman J., et al. Urine interleukin-6 is an early biomarker of acute kidney injury in children undergoing cardiac surgery. Crit Care 2010, 14:R181.
16. Cruz D.N., Goh C.Y., Haase-Fielitz A., Ronco C., Haase M. Early biomarkers of renal injury. Congest Heart Fail 2010, 16(Suppl. 1):S25-S31.
17. Katz J.N., Shah B.R., Volz E.M., et al. Evolution of the coronary care unit: clinical characteristics and temporal trends in healthcare delivery and outcomes. Crit Care Med 2010, 38:375-381.
18. Lin Y.S., Tang C.H., Yang C.Y., et al. Effect of pre-eclampsia-eclampsia on major cardiovascular events among peripartum women in Taiwan. Am J Cardiol 2011, 107:325-330.
19. Mehta R.L., Kellum J.A., Shah S.V., et al. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 2007, 11:R31.
20. Wald R., Liangos O., Perianayagam M.C., et al. Plasma cystatin C and acute kidney injury after cardiopulmonary bypass. Clin J Am Soc Nephrol 2010, 5:1373-1379.
21. Chang C.H., Lin C.Y., Tian Y.C., et al. Acute kidney injury classification: comparison of AKIN and RIFLE criteria. Shock 2010, 33:247-252.
22. Adams K.F., Fonarow G.C., Emerman C.L., et al. Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J 2005, 149:209-216.
23. Tsagalis G., Akrivos T., Alevizaki M., et al. Renal dysfunction in acute stroke: an independent predictor of long-term all combined vascular events and overall mortality. Nephrol Dial Transplant 2009, 24:194-200.
24. Mori K., Lee H.T., Rapoport D., et al. Endocytic delivery of lipocalin-siderophore-iron complex rescues the kidney from ischemia-reperfusion injury. J Clin Invest 2005, 115:610-621.
25. Kjeldsen L., Johnsen A.H., Sengelov H., Borregaard N. Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase. J Biol Chem 1993, 268:10425-10432.
26. Bolignano D., Coppolino G., Lacquaniti A., Buemi M. From kidney to cardiovascular diseases: NGAL as a biomarker beyond the confines of nephrology. Eur J Clin Invest 2010, 40:273-276.
27. Gupta K., Shukla M., Cowland J.B., Malemud C.J., Haqqi T.M. Neutrophil gelatinase-associated lipocalin is expressed in osteoarthritis and forms a complex with matrix metalloproteinase 9. Arthritis Rheum 2007, 56:3326-3335.
28. Hemdahl A.L., Gabrielsen A., Zhu C., et al. Expression of neutrophil gelatinase-associated lipocalin in atherosclerosis and myocardial infarction. Arterioscler Thromb Vasc Biol 2006, 26:136-142.
29. Merchant F.M., Weiner R.B., Rao S.R., et al. In-hospital outcomes of emergent and elective percutaneous coronary intervention in octogenarians. Coron Artery Dis 2009, 20:118-123.
30. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 1999, 340:115-126.
31. Davies M.J. A macro and micro view of coronary vascular insult in ischemic heart disease. Circulation 1990, 82:II38-II46.
32. Dogan I., Karaman K., Sonmez B., Celik S., Turker O. Relationship between serum neutrophil count and infarct size in patients with acute myocardial infarction. Nucl Med Commun 2009, 30:797-801.
33. Barron H.V., Harr S.D., Radford M.J., Wang Y., Krumholz H.M. The association between white blood cell count and acute myocardial infarction mortality in patients > or =65 years of age: findings from the cooperative cardiovascular project. J Am Coll Cardiol 2001, 38:1654-1661.
34. Jernberg T., Lindahl B., James S., Larsson A., Hansson L.O., Wallentin L. Cystatin C: a novel predictor of outcome in suspected or confirmed non-ST-elevation acute coronary syndrome. Circulation 2004, 110:2342-2348.
35. Taglieri N., Fernandez-Berges D.J., Koenig W., et al. Plasma cystatin C for prediction of 1-year cardiac events in Mediterranean patients with non-ST elevation acute coronary syndrome. Atherosclerosis 2010, 209:300-305.
36. Kilic T., Oner G., Ural E., et al. Comparison of the long-term prognostic value of cystatin C to other indicators of renal function, markers of inflammation and systolic dysfunction among patients with acute coronary syndrome. Atherosclerosis 2009, 207:552-558.
37. Windhausen F., Hirsch A., Fischer J., et al. Cystatin C for enhancement of risk stratification in non-ST elevation acute coronary syndrome patients with an increased troponin T. Clin Chem 2009, 55:1118-1125.
38. Zografos T., Haliassos A., Korovesis S., Giazitzoglou E., Voridis E., Katritsis D. Association of neutrophil gelatinase-associated lipocalin with the severity of coronary artery disease. Am J Cardiol 2009, 104:917-920.
39. Yamaoka-Tojo M., Tojo T., Wakaume K., et al. Circulating interleukin-18: a specific biomarker for atherosclerosis-prone patients with metabolic syndrome. Nutrition and Metabolism (London) 2011, 8:3.
40. Vlachopoulos C., Ioakeimidis N., Aznaouridis K., et al. Association of interleukin-18 levels with global arterial function and early structural changes in men without cardiovascular disease. Am J Hypertens 2010, 23:351-357.
41. Satoh-Asahara N., Suganami T., Majima T., et al. Urinary cystatin C as a potential risk marker for cardiovascular disease and chronic kidney disease in patients with obesity and metabolic syndrome. Clin J Am Soc Nephrol 2011, 6:265-273.
42. Parikh N.I., Hwang S.J., Larson M.G., et al. Indexes of kidney function and coronary artery and abdominal aortic calcium (from the Framingham Offspring Study). Am J Cardiol 2008, 102:440-443.
43. Nejat M., Pickering J.W., Devarajan P., Bonventre J.V., Edelstein C.L., Walker R.J., et al. Some biomarkers of acute kidney injury are increased in pre-renal acute injury. Kidney Int 2012, 81:1254-1262.
44. Singer E., Elger A., Elitok S., Kettritz R., Nickolas T.L., Barasch J., et al. Urinary neutrophil gelatinase-associated lipocalin distinguishes pre-renal from intrinsic renal failure and predicts outcomes. Kidney Int 2011, 80(4):405-414.